141 related articles for article (PubMed ID: 16217764)
41. [The value of urine cystein proteinase and serum CA125 measurement in monitoring the treatment of malignant ovarian tumor].
Gao G; Peng Z; He B
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):291-4. PubMed ID: 9389065
[TBL] [Abstract][Full Text] [Related]
42. E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.
Kothandaraman N; Bajic VB; Brendan PN; Huak CY; Keow PB; Razvi K; Salto-Tellez M; Choolani M
BMC Cancer; 2010 Feb; 10():64. PubMed ID: 20181230
[TBL] [Abstract][Full Text] [Related]
43. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2.
De Cecco L; Marchionni L; Gariboldi M; Reid JF; Lagonigro MS; Caramuta S; Ferrario C; Bussani E; Mezzanzanica D; Turatti F; Delia D; Daidone MG; Oggionni M; Bertuletti N; Ditto A; Raspagliesi F; Pilotti S; Pierotti MA; Canevari S; Schneider C
Oncogene; 2004 Oct; 23(49):8171-83. PubMed ID: 15377994
[TBL] [Abstract][Full Text] [Related]
44. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Yin BW; Dnistrian A; Lloyd KO
Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
[TBL] [Abstract][Full Text] [Related]
45. Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.
Le Page C; Ouellet V; Madore J; Ren F; Hudson TJ; Tonin PN; Provencher DM; Mes-Masson AM
Br J Cancer; 2006 Feb; 94(3):436-45. PubMed ID: 16421595
[TBL] [Abstract][Full Text] [Related]
46. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays.
Jiang W; Huang R; Duan C; Fu L; Xi Y; Yang Y; Yang WM; Yang D; Yang DH; Huang RP
PLoS One; 2013; 8(10):e76795. PubMed ID: 24116163
[TBL] [Abstract][Full Text] [Related]
47. Role of tumour markers in monitoring epithelial ovarian cancer.
Meyer T; Rustin GJ
Br J Cancer; 2000 May; 82(9):1535-8. PubMed ID: 10789720
[TBL] [Abstract][Full Text] [Related]
48. New technologies for the identification of markers for early detection of ovarian cancer.
Bandera CA; Ye B; Mok SC
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):51-5. PubMed ID: 12544502
[TBL] [Abstract][Full Text] [Related]
49. Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
Mills GB; Bast RC; Srivastava S
J Natl Cancer Inst; 2001 Oct; 93(19):1437-9. PubMed ID: 11584052
[No Abstract] [Full Text] [Related]
50. Identification and validation of differential plasma proteins levels in epithelial ovarian cancer.
Periyasamy A; Gopisetty G; Subramanium MJ; Velusamy S; Rajkumar T
J Proteomics; 2020 Aug; 226():103893. PubMed ID: 32634479
[TBL] [Abstract][Full Text] [Related]
51. Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.
Steele IA; Edmondson RJ; Leung HY; Davies BR
Growth Factors; 2006 Mar; 24(1):45-53. PubMed ID: 16393693
[TBL] [Abstract][Full Text] [Related]
52. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
[TBL] [Abstract][Full Text] [Related]
53. Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer.
Auersperg N; Maines-Bandiera S; Booth JH; Lynch HT; Godwin AK; Hamilton TC
Am J Obstet Gynecol; 1995 Aug; 173(2):558-65. PubMed ID: 7645635
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
Chatterjee M; Mohapatra S; Ionan A; Bawa G; Ali-Fehmi R; Wang X; Nowak J; Ye B; Nahhas FA; Lu K; Witkin SS; Fishman D; Munkarah A; Morris R; Levin NK; Shirley NN; Tromp G; Abrams J; Draghici S; Tainsky MA
Cancer Res; 2006 Jan; 66(2):1181-90. PubMed ID: 16424057
[TBL] [Abstract][Full Text] [Related]
55. CA125 and UQCRFS1 FISH studies of ovarian carcinoma.
Kaneko SJ; Gerasimova T; Smith ST; Lloyd KO; Suzumori K; Young SR
Gynecol Oncol; 2003 Jul; 90(1):29-36. PubMed ID: 12821338
[TBL] [Abstract][Full Text] [Related]
56. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.
Woong-Shick A; Sung-Pil P; Su-Mi B; Joon-Mo L; Sung-Eun N; Gye-Hyun N; Young-Lae C; Ho-Sun C; Heung-Jae J; Chong-Kook K; Young-Wan K; Byoung-Don H; Hyun-Sun J
Cancer Sci; 2005 Mar; 96(3):197-201. PubMed ID: 15771624
[TBL] [Abstract][Full Text] [Related]
57. Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients.
Richter C; Baetje M; Bischof A; Makovitzky J; Richter DU; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2023-5. PubMed ID: 17649816
[TBL] [Abstract][Full Text] [Related]
58. Altered expression of sialylated glycoproteins in ovarian cancer sera using lectin-based ELISA assay and quantitative glycoproteomics analysis.
Wu J; Xie X; Nie S; Buckanovich RJ; Lubman DM
J Proteome Res; 2013 Jul; 12(7):3342-52. PubMed ID: 23731285
[TBL] [Abstract][Full Text] [Related]
59. Quantum Dot-labeled Tags Improve Minimal Detection Limit of CA125 in Ovarian Cancer Cells and Tissues.
Shojaeian S; Allameh A; Jeddi-Tehrani M; Ghods R; Shojaeian J; Tabatabaei-Panah AS; Zarnani AH
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):326-335. PubMed ID: 30537796
[TBL] [Abstract][Full Text] [Related]
60. Expression of basic fibroblast growth factor and its mRNA in advanced ovarian cancers.
Fujimoto J; Ichigo S; Hori M; Hirose R; Sakaguchi H; Tamaya T
Eur J Gynaecol Oncol; 1997; 18(5):349-52. PubMed ID: 9378151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
